COMPOSITION PHARMACEUTIQUE DESTINÉE À SUPPRIMER L'APPÉTIT, CONTENANT DU N2- (M-TRIFLUOROBENZYLE), DE LA N6- (P-NITROBENZYL)PURINE (TNP) OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CETTE DERNIÈRE EN TANT QUE PRINCIPE ACTIFTNP(N2-(M-트리플루오로벤질), N6-(P-니트로벤질)퓨린) 또는 이의 약학적으로 허용가능한 염을 유효성분으로 함유하는 식욕억제용 약학적 조성물

Cited 0 time in webofscience Cited 0 time in scopus
  • Hit : 60
  • Download : 0
The present invention relates to a pharmaceutical composition containing TNP (N2-(m-Trifluorobenzyl), N6-(p-nitrobenzyl)purine) or a pharmaceutically acceptable salt thereof as an active ingredient for suppressing appetite. Particularly, TNP or a pharmaceutically acceptable salt thereof can be effectively used as an active ingredient of a pharmaceutical composition or a nutraceutical food for suppressing appetite since it is confirmed that food intake is reduced and weight gain is inhibited in mice when the central nervous system of mice is treated with TNP.
Assignee
KAIST, UNIV ULSAN FOUND FOR IND COOP
Country
FR (France)
Application Date
2017-04-11
Application Number
17782633.6
Registration Date
2020-03-25
Registration Number
3443963
URI
http://hdl.handle.net/10203/278203
Appears in Collection
BS-Patent(특허)
Files in This Item
There are no files associated with this item.

qr_code

  • mendeley

    citeulike


rss_1.0 rss_2.0 atom_1.0